Allo-APZ2-OTS

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
36	表皮水疱症	1

36. 表皮水疱症

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05464381 (ClinicalTrials.gov)	February 1, 2023	5/7/2022	Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (P ...	A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Tria ...	Epidermolysis Bullosa	Drug: allo-APZ2-OTS;Drug: Placebo	RHEACELL GmbH & Co. KG	NULL	Recruiting	N/A	N/A	All	74	Phase 3	Austria

First Previous1Next Last